Log in to save to my catalogue

Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease th...

Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease th...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2859748699

Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Glucagon-like peptide-1 (GLP-1) receptor agonists are established pharmaceutical therapies for the treatment of type 2 diabetes and obesity. They mimic the action of GLP-1 to reduce glucose levels through stimulation of insulin secretion and inhibition of glucagon secretion. They also reduce body weight by inducing satiety through central actions....

Alternative Titles

Full title

Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2859748699

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2859748699

Other Identifiers

ISSN

0012-186X,1432-0428

E-ISSN

1432-0428

DOI

10.1007/s00125-023-05929-0

How to access this item

Log in as a Library member